Vyome Holdings, Inc
HIND Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$1.71
KIRA · Stoqly’s AI analyst, in plain words
- Vyome Holdings, Inc had $0.3M of revenue in fiscal 2025, up 24.4% on the year before. Over five years, revenue changed −51.0% a year on average.
- Its operating margin was −3,269.5%, down 2,877.8 pts: of every 100 in sales, about −3,270 is left after running the business.
- Vyome Holdings, Inc lost $10.3M in fiscal 2025.
Market cap
$3.7M
P/E
0.0x
Revenue
$0.3M
Net income
−$10.3M
Free cash flow
—
Operating margin
−3,269.5%
Vyome Holdings, Inc in 30 seconds · fiscal 2025
Are sales growing?
+24.4%
Yes. Sales grew 24.4% last year.
Does it make a profit?
−3,209.9%
No. It lost money last year.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
0.0x
One share costs 0.0 times its yearly profit per share.
What Vyome Holdings, Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 18, 2026
- Legal name
- Vyome Holdings, Inc
- CIK
- 0001427570
Vyome Holdings, Inc · HIND
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $13.6M | $11.2M | $8.7M | $0.3M | $0.3M |
| Revenue growth | 20.4% | −17.4% | −22.8% | −97.0% | 24.4% |
| Gross margin | 61.4% | 60.5% | 63.9% | 75.9% | 68.4% |
| Operating margin | −425.6% | −412.4% | −177.3% | −391.7% | −3,269.5% |
| Net income | −$63.1M | −$46.2M | −$11.4M | −$1.4M | −$10.3M |
| Net margin | −464.3% | −411.2% | −131.2% | −563.4% | −3,209.9% |
| Diluted EPS | −$288.97 | −$108.90 | −$110.87 | −$6,001.39 | −$4.86 |
| Cash | |||||
| Cash from operations | −$15.4M | −$21.9M | −$17.0M | −$0.6M | −$3.7M |
| Capital expenditure | $0.4M | $0.1M | $0.0M | — | — |
| Free cash flow | −$15.7M | −$22.0M | −$17.0M | — | — |
| FCF margin | −115.6% | −196.0% | −195.9% | — | — |
| Share count change | −94.4% | 94.2% | −75.8% | −99.8% | 1,080,550.0% |
| Debt and strength | |||||
| Cash and short-term investments | $22.8M | $3.9M | $4.5M | $0.1M | $5.0M |
| Debt incl. finance leases | — | — | — | $0.8M | — |
| Shareholders' equity | $44.3M | $3.7M | $6.7M | −$4.4M | $3.8M |
| Current ratio | 4.0x | 1.3x | 2.7x | 0.1x | 2.0x |
| Interest coverage | — | — | — | −4.9x | −71.3x |
| Returns and quality | |||||
| Return on equity | −214.7% | −192.6% | −220.6% | −127.4% | — |
| Return on tangible equity | −207.3% | −1,358.8% | −170.9% | — | −297.6% |
| Piotroski F-score | 4 | 2 | 4 | 4 | 2 |
| Altman Z'' | −34.8 | −208.6 | −198.2 | −162.3 | −50.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Vyome Holdings, Inc · HIND
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.71 a share, the company is worth $3.7M: 0.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001427570). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.